The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.226%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 31.50
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Change of Name, Website and Messaging

5 Feb 2024 07:00

RNS Number : 9398B
Duke Royalty Limited
05 February 2024
 

5 February 2024

Duke Royalty Ltd

('Duke' or 'the Company')

Proposed Change of Name, New Website, Renewed Messaging and Investor Presentations

Duke is pleased to announce the outcome of its previously reported review of the SME Financing sector and to update the market on its proposed change of name to Duke Capital, new corporate website and renewed messaging.

Conclusions from our review

Duke's review has focused on ensuring that its unique offering is communicated to business owners and stakeholders in a way which provides greater clarity and improves comparison when evaluating a broad array of financing options. We believe this is in the best interest of the Company and its shareholders for the following reasons:

· The global private credit market is a large, rapidly growing and evolving segment of the financial sector, which includes direct lending, mezzanine, high-yield debt and other alternative products such as royalties

· Private credit, and especially direct lending (ie non-bank lending) has become more widely accepted in the SME sector in the last decade, and we believe Duke's solution is best classified as direct lending

· Duke has a seven-year track record in providing long-term, unique financing solutions to the lower mid-market in the UK, Europe and North America with current invested capital of over £200 million

· During that time, traditional royalty companies in the mining, music and pharmaceutical sectors have proliferated, especially in the public markets, which has resulted in confusion about Duke's solution for lower mid-market businesses which has, to date, been known as 'corporate royalties'

· By reframing our product as 'hybrid capital', we can more easily convey the attributes of our financing solution to business owners and investors and build on our momentum

· We define hybrid capital as a financing solution that blends features of private equity and private credit products and is more flexible than traditional debt or equity alone

· Despite the name change, our core product, investing policy and investment criteria are not changing, and we will continue to provide business owners with our unique 'corporate mortgage' debt product with equity-like attributes which align our success with the success of the business

Additional flexibility for investing 

· Going forward, Duke will have additional flexibility to take equity ownership over 30% if and when situations necessitate or there is clear rationale to do so for our shareholders. The Company will maintain the same investment approach which, unlike private equity, is not looking to take control of the business or force an exit

· This additional flexibility is intended to benefit investors by enabling Duke in certain circumstances to continue longer with our best performing partners and ensure our capital growth is maximised, while not affecting our recurring cash revenue during the investment

· Duke will continue to focus on receiving monthly recurring cash revenue from its partners, and will continue to invest in profitable, long-established private businesses which provide investors with exposure to a broad range of sectors in UK, Western Europe and North America

Name change to Duke Capital  

· To reflect our renewed messaging, Duke proposes to change its name to Duke Capital Limited following an Extraordinary General Meeting ("EGM"), further details of which can be found below

· Other than the change of name, there will be no change to the dividend policy, the stock symbol (ticker) or the shares outstanding

· The Company has launched a new corporate website: www.dukecapital.com

Duke CEO Neil Johnson said, "I'm excited to share the findings of our recent review of our positioning in the marketplace. Over the past seven years we have talked to hundreds of business owners looking to receive capital but retain control and have listened to what resonates with them about having Duke as a partner. Making the features of our product more easily relatable versus other financing options gives us a bigger opportunity to engage with more business owners who are used to thinking in either 'debt' or 'equity'.

"Investors are likely aware that the private credit and private equity sectors continue to converge, and we believe Duke has been at the forefront of this convergence for many years. By clarifying how we describe our product, we aim to appeal to a broader cross-section of investors who want exposure to Duke's unique and proven private credit offering.

"This evolving industry is also rapidly growing. In particular, Blackrock estimates direct lending has increased over six-fold in the last decade to $650 billion and is now the largest segment of the private credit market. With our renewed positioning and additional flexibility, we believe we can become an increasingly important lower mid-market capital provider which will benefit both shareholders and business owners alike."

Proposed change of name and Notice of EGM

Duke provides notice of an Extraordinary General Meeting to be held at 10:30 a.m. on 20 February 2024 at the Company's registered office, Ground Floor, Cambridge House, Le Truchot, St Peter Port, Guernsey, GY1 1WD to approve its change of name to Duke Capital Limited (the "Notice"). The Notice is today being posted to shareholders, together with an accompanying form of proxy, an electronic copy of which will shortly be available to view on the Company's website.

 

The Company's TIDM, 'DUKE', will remain unchanged as will its ISIN.

 

The Company will make a further announcement following the EGM to confirm once the name change is effective.

 

Investor Presentations

 

The management team is available to update shareholders at the following events and will also put recordings on the website when they become available.

 

AJ Bell 'LIVE' Investor Evening

 

Duke will be presenting at the Shares and AJ Bell 'LIVE' investor evening in London on Tuesday 6 February 2024, starting at 17:15, at the Novotel Tower Bridge, London EC3N 2NR.

 

Neil Johnson, CEO, will present the latest developments and available to answer questions. If you would like to attend, you can register for the event here.

 

MelloMonday

 

Duke will be presenting at the MelloMonday webinar on Monday 19 February 2024 starting at 5pm via Zoom Webinar.

 

Neil Johnson, CEO, will be providing a trading update to webinar participants during the event and will be taking questions after. If you would like to attend, you can register here for a free ticket for the event using code SHR100. The recording will be sent out to all registrants within 48 hours of the event.

 

 

**ENDS**

 

For further information, please visit www.dukecapital.com, or contact:

 

 

Duke

Neil Johnson / Charles Cannon Brookes / Hugo Evans 

 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson 

+44 (0) 207 220 0500

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Alice Cho / Matthew Elliott

+44 (0) 20 3757 6882

duke@secnewgate.co.uk

 

About Duke

 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. It's three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits.

 

Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGIGDDXDGDGSS
Date   Source Headline
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.